Charlie's Holdings, Inc. 10-Q

ITEM 1. FINANCIAL STATEMENTS     CHARLIE ’ S HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts)       March 31,     December 31,       2022     2021       (Unaudited)           ASSETS                 Current assets:                 Cash   $ 409     $ 866   Accounts receivable, net     1,717       1,368   Inventories, net     4,696       5,005   Prepaid expenses and other current assets     1,226       755   Total current assets     8,048       7,994                     Non-current assets:                 Property, plant and equipment, net     449       431   Right-of-use asset, net     638       755   Other assets     70       68   Total non-current assets     1,157       1,254                     TOTAL ASSETS   $ 9,205     $ 9,248                     LIABILITIES AND STOCKHOLDERS' EQUITY                 Current liabilities:                 Accounts payable and accrued expenses   $ 3,684     $ 4,068   Derivative liability     559       899   Lease liabilities     265       329   Deferred revenue     316       238   Total current liabilities     4,824       5,534                     Non-current liabilities:                 Notes payable, net of current portion     150       150   Lease liabilities, net of current portion     376       433   Total non-current liabilities     526       583                     Total liabilities     5,350       6,117                     COMMITMENTS AND CONTINGENCIES (see Note 12)                                       Stockholders' equity:                 Convertible preferred stock ($ 0.001 par value); 1,800,000 shares authorized                 Series A, 300,000 shares designated, 141,123 and 141,873 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively     -       -   Series B, 1,500,000 shares designated, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively     -       -   Common stock ($ 0.001 par value); 500,000,000 shares authorized; 216,840,987 and 210,890,930 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively     217       211   Additional paid-in capital     7,787       7,775   Accumulated deficit     ( 4,149 )     ( 4,855 ) Total stockholders' equity     3,855       3,131   TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   $ 9,205     $ 9,248     The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.     -1- Table of Contents       CHARLIE ’ S HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share amounts) (Unaudited)       For the three months ended       March 31,       2022     2021   Revenues:                 Product revenue, net   $ 8,074     $ 4,361   Total revenues     8,074       4,361   Operating costs and expenses:                 Cost of goods sold - product revenue     4,434       1,943   General and administrative     2,559       2,218   Sales and marketing     703       420   Research and development     11       9   Total operating costs and expenses     7,707       4,590   Income (loss) from operations     367       ( 229 ) Other income (expense):                 Interest expense     ( 1 )     ( 28 ) Change in fair value of derivative liabilities     340       ( 20,102 ) Gain on debt extinguishment     -       217   Other income     -       5   Total other income (loss)     339       ( 19,908 ) Net income (loss)   $ 706     $ ( 20,137 )                   Net earnings (loss) per share                 Basic   $ 0.00     $ ( 0.10 ) Diluted   $ 0.00     $ ( 0.10 ) Weighted average number of common shares outstanding                 Basic     211,007,522       195,141,950   Diluted     242,854,761       195,141,950     The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.   -2- Table of Contents       CHARLIE ’ S HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS ’ EQUITY (DEFICIT) (in thousands) (Unaudited)       For the Three Months Ended March 31, 2022       Series Convertible Preferred Stock     Common Stock     Additional     Accumulated     Total Stockholders ’         Shares     Par value     Shares     Par value     Paid-in Capital     Deficit     Equity   Balance at January 1, 2022     142     $ -       210,890     $ 211     $ 7,775     $ ( 4,855 )   $ 3,131   Conversion of Series A convertible preferred stock     ( 1 )     -       169       -       -       -       -   Stock compensation     -       -       5,781       6       12       -       18   Net income     -       -       -       -       -       706       706   Balance at March 31, 2022     141     $ -       216,840     $ 217     $ 7,787     $ ( 4,149 )   $ 3,855         For the Three Months Ended March 31, 2021       Series A                                               Series Convertible Preferred Stock     Common Stock     Additional     Accumulated     Total Stockholders ’         Shares     Par value     Shares     Par value     Paid-in Capital     Deficit     Deficit   Balance at January 1, 2021     204     $ -       189,907     $ 190     $ 3,477     $ ( 9,663 )   $ ( 5,996 ) Issuance of common stock to related parties for cash     -       -       3,517       3       2,997       -       3,000   Conversion of Series A convertible preferred stock     ( 25 )     -       5,669       6       ( 6 )     -       -   Issuance of common stock for dividend payment     -       -       203       -       90             90   Stock compensation     -       -       -       -       359       -       359   Net loss     -       -       -       -       -       ( 20,137 )     ( 20,137 ) Balance at March 31, 2021     179     $ -       199,296     $ 199     $ 6,917     $ ( 29,800 )   $ ( 22,684 )   The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.   -3- Table of Contents       CHARLIE ’ S HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (Unaudited)       For the three months ended       March 31,       2022     2021   Cash Flows from Operating Activities:                 Net income (loss)   $ 706     $ ( 20,137 ) Reconciliation of net income (loss) to net cash (used in) provided by operating activities:                 Allowance for doubtful accounts     97       ( 12 ) Depreciation and amortization     67       50   Change in fair value of derivative liabilities     ( 340 )     20,102   Amortization of operating lease right-of-use asset     117       113   Stock based compensation     18       359   Gain from debt extinguishment     -       ( 217 ) Subtotal of non-cash charges     ( 41 )     20,395   Changes in operating assets and liabilities:                 Accounts receivable     ( 446 )     189   Inventories     309       2   Prepaid expenses and other current assets     ( 471 )     96   Other assets     ( 2 )     -   Accounts payable and accrued expenses     ( 384 )     ( 336 ) Deferred revenue     78       174   Lease liabilities     ( 121 )     ( 115 ) Net cash (used in) provided by operating activities     ( 372 )     268   Cash Flows from Investing Activities:                 Purchase of property, plant and equipment     ( 85 )     ( 19 ) Net cash used in investing activities     ( 85 )     ( 19 ) Cash Flows from Financing Activities:                 Proceeds from issuance of common stock to related parties     -       3,000   Proceeds from issuance of notes payable     -       184   Repayment of notes payable     -       ( 1,400 ) Net cash provided by financing activities     -       1,784   Net (decrease) increase in cash     ( 457 )     2,033                     Cash, beginning of the period     866       1,422   Cash, end of the period   $ 409     $ 3,455                     Supplemental disclosure of cash flow information                 Cash paid for interest   $ -     $ 150   Cash paid for income taxes   $ -     $ -                     Supplemental disclosure of cash flow information                 Conversion of Series A convertible preferred stock   $ -     $ 567   Issuance of common stock for dividend payment   $ -     $ 90   Gain from debt extinguishment   $ -     $ 217     The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.   -4- Table of Contents     CHARLIE'S HOLDINGS, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)     NOTE 1 – DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION   Description of the Business   Charlie’s Holdings, Inc., (formerly True Drinks Holdings, Inc.) a Nevada corporation, together with its wholly-owned subsidiaries and consolidated variable interest entity (collectively, the “ Company ”, “ we ”), currently formulates, markets, and distributes premium, nicotine-based vapor products. The Company’s products are produced domestically by contract manufacturers for sale by select distributors, specialty retailers and third -party online resellers throughout the United States, as well as in more than 80 countries worldwide. The Company’s primary international markets include the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada. In June 2019 , The Company launched distribution of certain premium vapor, ingestible and topical products containing hemp-derived cannabidiol (“ CBD ”) and other compounds derived from hemp through Don Polly, a Nevada limited liability company that is owned by entities controlled by Brandon and Ryan Stump, the Company's former Chief Executive Officer and current Chief Operating Officer, respectively, and a consolidated variable interest for which the Company is the primary beneficiary (“ Don Polly ”). Our hemp-based products are produced, marketed and sold through Don Polly, and the Company intends to develop and launch additional products containing hemp-derived cannabinoids in the future.   In addition to Don Polly, we also wholly-own Charlie’s Chalk Dust, LLC (“ Charlie ’ s ” or “ CCD ”), which also produces and sells our premium, nicotine-based vapor products.   The Company's common stock, par value $ 0.001 per share (the “ Common Stock ”), trades under the symbol "CHUC" on the OTCQB Venture Market.   Reverse Stock Split   The Company’s Board of Directors approved a reverse stock split of the Company’s authorized, issued and outstanding shares of Common Stock, at a ratio of 1 -for- 100 (the “ Reverse Split ”). The Reverse Split was effective as of June 16, 2021 (the “ Effective Date ”). All share and per share amounts in this quarterly report on Form 10 -Q (this “ Report ”) have been retroactively adjusted to account for the Reverse Split.   Going Concern Uncertainty Regarding the Legal and Regulatory Environment, Liquidity and Management ’ s Plan of Operation   Our financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company operates in a rapidly changing legal and regulatory environment; new laws and regulations or changes to existing laws and regulations could significantly limit the Company’s ability to sell its products, and/or result in additional costs. Additionally, the Company was required to apply for FDA approval to continue selling and marketing its products used for the vaporization of nicotine in the United States. Currently, a substantial portion of the Company’s sales are derived from products that are subject to approval by the United States Food and Drug Administration (“ FDA ”). There was significant cost associated with the application process and there can be no assurance the FDA will approve previous and/or future applications. In addition, the outbreak of a novel strain of COVID- 19 (“ Coronavirus ”) which was identified in Wuhan, China around December 2019, has had a negative impact on the global economy and the Company’s supply chain and sales. For the three months ended March 31, 2022, the Company generated income from operations of approximately $ 0.4 million, and a consolidated net income of approximately $ 0.7 million, but used cash in operations of approximately $ 0.4 million. The Company had stockholders’ equity of $ 3.9 million at March 31, 2022. During the three months ended March 31, 2022, the Company’s working capital requirements continued to evolve as current assets, excluding cash, increased to $ 7.6 million from $ 7.1 million as of December 31, 2021, and cash on hand decreased to $ 0.4 million from $ 0.9 million as of December 31, 2021. Considering these facts, the issuance of one or several Marketing Denial Orders (“ MDO ”) from the FDA would increase the potential for inventory obsolescence and uncollectable accounts receivables. These regulatory risks, as well as other industry-specific challenges remain factors that raise substantial doubt about the Company’s ability to continue as a going concern.   - 5 - Table of Contents     Management's plans depend on its ability to increase revenues, raise additional capital, and continue its business development efforts, including the expenditure of approximately $ 4,400,000 to date, to complete the Pre-Market Tobacco Application (“ PMTA ”) process for the Company’s 2020 submissions to the FDA. In 2022 the Company intends to allocate further resources and new personnel to support research and development initiatives in order to submit one or more additional PMTAs. The Company may require additional financing in the future to support subsequent PMTA filings, and/or in the event the FDA requests additional testing for one, or several, of the Company’s prior PMTA submissions. There can be no assurance that additional financing will be available on acceptable terms, or at all, and there can be no assurance that any such arrangement, if required or otherwise sought, would be available on terms deemed to be commercially acceptable and, in the Company’s best interests. The financial statements do not include any adjustments to the carrying amount and classification of recorded assets and liabilities should the Company be unable to continue operations.   Risks and Uncertainties   The Company operates in an environment that is subject to rapid changes and developments in laws and regulations that could have a significant impact on the Company’s ability to sell its products. Beginning in September 2019, certain states temporarily banned the sale of flavored e-cigarettes, and several states and municipalities are considering implementing similar restrictions. Federal, state, and local governmental bodies across the United States have indicated that flavored e-cigarette liquid, vaporization products and certain other consumption accessories may become subject to new laws and regulations at the federal, state, and local levels. The application of any new laws or regulations that may be adopted in the future, at a federal, state, or local level, directly or indirectly implicating flavored e-cigarette liquid and other electronic nicotine delivery system (“ ENDS ”) products, could significantly limit the Company’s ability to sell such products, result in additional compliance expenses, and/or require the Company to change its labeling and/or methods of distribution. Any ban of the sale of flavored e-cigarettes directly limits the markets in which the Company may sell its products. In the event the prevalence of such bans and/or changes in laws and regulations increase across the United States, or internationally, the Company’s business, results of operations and financial condition could be adversely impacted. In addition, the Company is presently seeking to obtain marketing authorization for certain of its tobacco-derived nicotine e-liquid products. The Company’s applications were submitted in September 2020 on a timely basis, which if approved, will allow the Company to continue to sell its approved products in the United States. Beginning in August 2021, the FDA began issuing Marketing Denial Orders (“ MDO ”) for ENDS products that lack evidence to demonstrate that permitting the marketing of such products would be appropriate for the protection of the public health. The Company has not received an MDO for any of its submissions; however there is no assurance that regulatory approval to sell our products will be granted or that we would be able to raise additional financing if required, which could have a significant impact on our sales. On March 15, 2022, a new rider to the Federal Food, Drug and Cosmetic Act was passed granting the FDA authority over synthetic nicotine.  These regulations make the Company’s synthetic nicotine products subject to the same FDA rules as tobacco-derived nicotine products.  As such, the Company was required to file a PMTA for its existing synthetic nicotine products marketed under the Pacha Syn brands by May 14, 2022 or be subject to FDA enforcement.  The Company filed new PMTAs, for its synthetic Pacha Syn products on May 13, 2022, prior to the May 14, 2022 deadline.   On March 11, 2020, the World Health Organization designated the ongoing and evolving COVID- 19 outbreak as a pandemic. The outbreak has caused and continues to cause periodic disruption in international and U.S. economies and markets. The outbreak is having a temporary adverse impact on our industry as well as our business, with regards to certain supply chain disruptions and sales volume. While the disruption from COVID- 19 is currently expected to be temporary, there is uncertainty around the duration. The impact from COVID- 19 has affected our supply chain, and if disruptions from the COVID- 19 outbreak are prolonged, it will continue to have an adverse impact on our business.     NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Presentation   The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “ SEC ”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“ U.S. GAAP ”) have been omitted pursuant to such Securities and Exchange Commission (“ SEC ”) rules and regulations; nevertheless, the Company believes that the disclosures are adequate to make the information presented in this Report not misleading.   Amounts related to disclosure of December 31, 2021 balances within the interim condensed consolidated financial statements were derived from audited financial statements and notes thereto included in the Company’s Form 10 -K for the year ended December 31, 2021 ( the “ 2021 Annual Report ”).   Use of Estimates   The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.   - 6 - Table of Contents     Significant Accounting Policies   There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2021 Annual Report.   Recent Accounting Standards     In June 2016, the Financial Accounting Standards Board (“ FASB ”) issued Accounting Standards Update (“ ASU ”) No. 2016 - 13, “ Measurement of Credit Losses on Financial Instruments ” (“ ASU 2016 - 13 "), which supersedes current guidance requiring recognition of credit losses when it is probable that a loss has been incurred. ASU 2016 - 13 requires the establishment of an allowance for estimated credit losses on financial assets, including trade and other receivables, at each reporting date. ASU 2016 - 13 will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. ASU 2016 - 13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is permitted. The Company does not believe the impact of adopting this standard will be material to its condensed consolidated financial statements and related disclosures.   In August 2020, the FASB issued ASU No. 2020 - 06, “ Debt - Debt with Conversion and Other Options (Subtopic 470 - 20 ) and Derivatives and Hedging - Contracts in Entity ’ s Own Equity ” (“ ASU 2020 - 06 ”). ASU 2020 - 06 eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, ASU 2020 - 06 modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted earnings per share ( “ EPS ”) computation. The amendments in ASU 2020 - 06 are effective for smaller reporting companies as defined by the SEC for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020 - 06 on its condensed consolidated financial statements.   In May 2021, the FASB issued ASU No.   2021 - 04, “ Earnings Per Share (Topic 260 ), Debt-Modifications and Extinguishments (Subtopic 470 - 50 ), Compensation-Stock Compensation (Topic 718 ), and Derivatives and Hedging-Contracts in Entity ’ s Own Equity (Subtopic 815 - 40 ) ” (“ ASU 2021 - 04 ”). ASU 2021 - 04 reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. ASU 2021 - 04 provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: ( 1 ) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; ( 2 ) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and ( 3 ) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. ASU 2021 - 04 will be adopted for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company does not believe the impact of adopting this standard will be material to its condensed consolidated financial statements and related disclosures.     NOTE 3 – FAIR VALUE MEASUREMENTS   In accordance with Accounting Standards Codification (“ ASC ”) Topic 820 “ Fair Value Measurements and Disclosures ” (“ ASC 820 ”), the Company uses various inputs to measure the outstanding warrants on a recurring basis to determine the fair value of the liability. ASC 820 also establishes a hierarchy categorizing inputs into three levels used to measure and disclose fair value. The hierarchy gives the highest priority to quoted prices available in active markets and the lowest priority to unobservable inputs. An explanation of each level in the hierarchy is described below:   Level 1 - Unadjusted quoted prices in active markets for identical instruments that are accessible by the Company on the measurement date.   Level 2 - Quoted prices in markets that are not active or inputs which are either directly or indirectly observable.   Level 3 - Unobservable inputs for the instrument requiring the development of assumptions by the Company.   - 7 - Table of Contents     The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of March 31, 2022, and December 31, 2021 ( amounts in thousands):       Fair Value at March 31, 2022       Total     Level 1     Level 2     Level 3   Liabilities:                                 Derivative liability - Warrants     559       -       -       559   Total liabilities   $ 559     $ -     $ -     $ 559         Fair Value at December 31, 2021       Total     Level 1     Level 2     Level 3   Liabilities:                                 Derivative liability - Warrants     899       -       -       899   Total liabilities   $ 899     $ -     $ -     $ 899     There were no transfers between Level 1, 2 or 3 during the three -month period ended March 31, 2022.   The following table presents changes in Level 3 liabilities measured at fair value for the three -month period ended March 31, 2022. Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs (amounts in thousands).       Derivative liability - Warrants   Balance at January 1, 2022   $ 899   Change in fair value     ( 340 ) Balance at March 31, 2022   $ 559     A summary of the weighted average (in aggregate) significant unobservable inputs (Level 3 inputs) used in the Monte Carlo simulation measuring the Company’s derivative liabilities that are categorized within Level 3 of the fair value hierarchy as of March 31, 2022, and December 31, 2021, is as follows:       March 31,     December 31,       2022     2021   Exercise price   $ 0.4431     $ 0.4431   Contractual term (years)     2.07       2.32   Volatility (annual)     90.0 %     90.0 % Risk-free rate     2.3 %     0.8 % Dividend yield (per share)     0 %     0 %   On April 26, 2019 ( the “ Closing Date ”), the Company entered into a Securities Exchange Agreement (“ Share Exchange ”) with each of the former members (“ Members ”) of Charlie’s, and certain direct investors in the Company (“ Direct Investors ”), pursuant to which the Company acquired all outstanding membership interests of Charlie’s beneficially owned by the Members in exchange for the issuance by the Company of units. Immediately prior to, and in connection with, the Share Exchange, Charlie’s consummated a private offering of membership interests that resulted in net proceeds to Charlie’s of approximately $ 27.5 million (the “ Charlie ’ s Financing ”). In conjunction with the Share Exchange, the Company issued to holders of its Series A Convertible Preferred Stock, par value $ 0.001 per share (“ Series A Preferred ”), warrants to purchase an aggregate of 31,028,996 shares of Common Stock (the “ Investor Warrants ”) and to its placement agent, Katalyst Securities LLC, warrants to purchase an aggregate of 9,308,699 shares of Common Stock (the “ Placement Agent Warrants ”). Both the Investor Warrants and Placement Agent Warrants have a five -year term and a strike price of $ 0.44313 per share. Due to the exercise features of these warrants, they are not considered to be indexed to the Company’s own stock and are therefore not afforded equity treatment in accordance with ASC Topic 815, “ Derivatives and Hedging ” (“ ASC 815 ”). In accordance with ASC 815, the Company has recorded the Investor Warrants and Placement Agent Warrants as derivative instruments on its consolidated balance sheet. ASC 815 requires derivatives to be recorded on the balance sheet as an asset or liability and to be measured at fair value. Changes in fair value are reflected in the Company’s earnings for each reporting period.   - 8 - Table of Contents       NOTE 4 - PROPERTY AND EQUIPMENT   Property and equipment as of March 31, 2022, and December 31, 2021, are as follows (amounts in thousands):       March 31,     December 31,         2022     2021   Estimated Useful Life (in Years) Machinery and equipment   $ 46     $ 42   5 Trade show booth     227       171   5 Office equipment     536       511   5 Leasehold improvements     380       380   Lesser of lease term or estimated useful life       1,189       1,104     Accumulated depreciation     ( 740 )     ( 673 )       $ 449     $ 431       Depreciation and amortization expense totaled $ 67,000 and $ 50,000 , respectively, during the three months ended March 31, 2022 and 2021.     NOTE 5 - CONCENTRATIONS   Vendors   The Company’s concentration of purchases is as follows:       For the three months ended       March 31,       2022     2021   Vendor A     35 %     37 % Vendor B     28 %     - % Vendor C     13 %     - % Vendor D     - %     14 %   During the three months ended March 31, 2022 and 2021, purchases from three vendors represented 76 % and 51 %, respectively, of total inventory purchases.   As of March 31, 2022, and December 31, 2021, amounts owed to these vendors totaled $ 780,000 and $ 1,494,000 , respectively, which are included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets.   Accounts Receivable   The Company’s concentration of accounts receivable is as follows:       March 31,     December 31,       2022     2021   Customer A     22 %     27 %   One customer made up more than 22 % of net accounts receivable at March 31, 2022. The same customer made up more than 27 % of net accounts receivable at December 31, 2021. Customer A owed the Company a total of $ 356,000 representing 22 % of net receivables at March 31, 2022. Customer A owed the Company a total of $ 454,000 , representing 27 % of net receivables at December 31, 2021. No customer exceeded 10% of total net sales for the three -month periods ended March 31, 2022 and 2021.     - 9 - Table of Contents Table of Contents         NOTE 6 – DON POLLY, LLC   Don Polly is a Nevada limited liability company that is owned by entities controlled by Brandon and Ryan Stump, a former and current executive officer of the Company, respectively, and a consolidated variable interest for which the Company is the primary beneficiary. Don Polly formulates, sells and distributes the Company’s hemp-derived product lines.   We evaluate our ownership, contractual and other interests in entities that are not wholly-owned to determine if these entities are variable interest entities (“ VIEs ”), and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both ( 1 ) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and ( 2 ) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. Effective April 25, 2019, we began consolidating the financial statements of Don Polly and it is still considered a VIE of the Company.   Don Polly operates under exclusive licensing and service contracts with the Company whereby the Company receives 75 % of net income from the licensing agreement and 25 % of net income from the service agreement; therefore, as the Company receives 100 % of the net income or incurs 100% of the net loss of the VIE, no non-controlling interests are recorded.     NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES   Accounts payable and accrued expenses as of March 31, 2022, and December 31, 2021, are as follows (amounts in thousands):       March 31,     December 31,       2022     2021   Accounts payable   $ 1,806     $ 2,476   Accrued compensation     896       902   Accrued income taxes     342       342   Other accrued expenses     640       348       $ 3,684     $ 4,068       NOTE 8 – NOTES PAYABLE   Red Beard Holdings, LLC Note Payable   On April 1, 2020, the Company, Charlie's and its VIE, Don Polly, issued a secured promissory note (the " Red Beard Note ") to one of the Company's largest stockholders, Red Beard Holdings, LLC (" Red Beard "), in the principal amount of $ 750,000 (the " Principal Amount "), and required a guaranteed minimum interest amount of $ 75,000 (“ Minimum Interest ”). The Red Beard Note was secured by all assets of the Company pursuant to the terms of a Security Agreement entered into by and between the Company and Red Beard (the " Red Beard Note Financing "). The Red Beard Note was subsequently amended on August 27, 2020, September 30, 2020, October 29, 2020, December 1, 2020, and January 19, 2021, ultimately increasing Principal Amount to $ 1,400,000 and Minimum Interest to $ 150,000 .   On March 24, 2021, the Company and Red Beard entered into a Satisfaction and Release (the " Red Beard Release "), pursuant to which the Company made a payment to Red Beard in the amount of $ 1,550,000 in exchange for an acknowledgment of satisfaction and full release of the Company by Red Beard from liability and obligations arising under the Red Beard Note.   - 10 - Table of Contents     Small Business Administration Loan Programs   On April 30, 2020, Charlie's received approval to enter into a U.S. Small Business Administration (" SBA ") Promissory Note (the " PPP Loan Agreement ") with TBK Bank, SSB (the " SBA Lender "), pursuant to the Paycheck Protection Program (" PPP ") of the Coronavirus Aid, Relief, and Economic Security Act (the " CARES Act ") as administered by the SBA (the " Charlie's PPP Loan ").   The Charlie's PPP Loan provided for working capital to Charlie’s in the amount of $ 650,761 . The Charlie's PPP Loan was set to mature on April 30, 2022 and accrued interest at a rate of 1.00% per annum. Per the PPP Loan Agreement, payments of principal and interest were deferred for six months from the date of the Charlie's PPP Loan, or until November 30, 2020. Interest, however, continued to accrue during that time. Charlie’s was notified by SBA Lender that all payments, including principal and interest, on all PPP loans issued by the bank have been deferred indefinitely in order to allow borrowers adequate time to apply for forgiveness.   On April 14, 2020, Don Polly also obtained a loan pursuant to the PPP enacted under the CARES Act (the " Polly PPP Loan " and together with the Charlie's PPP Loan, the " PPP Loans ") from Community Banks of Colorado, a division of NBH Bank (the " Polly Lender "). The Polly PPP Loan provided for working capital to Don Polly in the amount of $ 215,600 . The Polly PPP Loan was set to mature on April 14, 2022 and accrued interest at a rate of 1.00% per annum. Payments of principal and interest were deferred for six months from the date of the Polly PPP Loan, or until November 14, 2020. Interest, however, continued to accrue during that time.   The aforementioned PPP Loans were made under the PPP enacted by Congress under the CARES Act. The CARES Act (including the guidance issued by SBA and U.S. Department of the Treasury) provides that all or a portion of the PPP Loans may be forgiven upon request from the respective borrower to the SBA Lender or the Polly Lender, as the case may be, subject to requirements in the PPP Loans and under the CARES Act.   On February 19, 2021, Don Polly received notice from the Polly Lender, that the Polly PPP Loan was fully repaid, and its promissory note was cancelled as a result of the loan forgiveness process set forth by the SBA. There is no further action required on the part of Don Polly to satisfy this liability. For the period ended March 31, 2021, the Company recorded a debt extinguishment gain of approximately $ 217,000 , including principal and accrued interest, which is reflected in the other income section of the Company’s consolidated statements of operations.   On March 17, 2021, Don Polly obtained a second draw PPP loan (“ Polly PPP Loan 2 ”) under the CARES Act from Polly Lender. The Polly PPP Loan 2 obtained by Don Polly provided general working capital in the amount of $ 184,200 . The Polly PPP Loan 2 was set to mature on March 17, 2026, and accrued interest at a rate of 1.00% per annum. Payments of principal and interest were deferred, however interest continued to accrue during that time.   During the year ended December 31, 2021, Charlie’s received notice from SBA Lender that the Charlie’s PPP Loan was fully repaid, and its promissory note was cancelled as a result of the loan forgiveness process set forth by the SBA. There is no further action required on the part of Charlie’s to satisfy this liability.   During the year ended December 31, 2021, Don Polly received notice from the Polly Lender that the Polly PPP Loan 2 was fully repaid, and its promissory note was cancelled as a result of the loan forgiveness process set forth by the SBA. There is no further action required on the part of Don Polly to satisfy this liability.   During the year ended December 31, 2021, the Company recorded a debt extinguishment gain of approximately $ 1,060,000 , including principal and accrued interest, which is reflected in the other income section of the Company’s consolidated statements of operations.   On June 24, 2020, SBA authorized (under Section 7 (b) of the Small Business Act, as amended) an Economic Injury Disaster Loan (“ EID Loan ”) to Don Polly in the amount of $ 150,000 . Installment payments, including principal and interest of $ 731 monthly, will begin thirty months from the date of the EID Loan. The balance of principal and interest will be payable thirty years from the date of the EID Loan and interest will accrue at the rate of 3.75 % per annum.     - 11 - Table of Contents     April 2022 Note Financing   On April 6, 2022, Charlie's Holding's, Inc., its wholly-owned subsidiary, Charlie's Chalk Dust, LLC and its variable interest entity, Don Polly LLC (collectively, the " Company "), issued a secured promissory note (" Note ") to one of the Company's largest stockholders, Michael King (the " Lender ") in the principal amount of $ 1,000,000 , which Note is secured by certain assets of the Company pursuant to the terms of a Security Agreement entered into by and between the Company and the Lender (the " Note Financing ").   The Note requires the payment of principal and guaranteed interest in the amount of at least $ 90,000 on or before the earlier date of (i) a Liquidity Event, as defined under the terms of the Note; or (ii) September 28, 2022. The Company intends to use the proceeds from the Note Financing for general corporate purposes, and its working capital requirements, pending the availability of alternative debt financing.   The following summarizes the Company’s notes payable maturities as of March 31, 2022 ( amounts in thousands):   Remaining months Ending December 31, 2022   $ -   Year Ending December 31, 2023     -   Year Ending December 31, 2024     -   Year Ending December 31, 2025     -   Thereafter     150   Total   $ 150       NOTE 9 – EARNINGS (LOSS) PER SHARE APPLICABLE TO COMMON STOCKHOLDERS   Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period. Diluted earnings (loss) per common share is computed similar to basic earnings (loss) per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted weighted average common shares include common stock potentially issuable under the Company’s convertible preferred stock, warrants and vested and unvested stock options.   For the three  months ended March 31, 2022, and 2021, net income (loss) is adjusted for gain from change in fair value of warrant liabilities.   The following table sets forth the computation of earnings (loss) per share (amounts in thousands, except share and per share amounts):       For the three months ended       March 31,       2022     2021   Net income (loss) - basic   $ 706     $ ( 20,137 ) Reversal of gain due to change in fair value of warrant liability     ( 340 )     -   Net income (loss) - diluted   $ 366     $ ( 20,137 )                   Weighted average shares outstanding - basic     211,007,522       195,141,950   Diluted preferred shares     31,847,239       -   Weighted average shares outstanding - diluted     242,854,761       195,141,950                     Basic earnings (loss) per share   $ 0.00     $ ( 0.10 ) Diluted earnings (loss) per share   $ 0.00     $ ( 0.10 )     - 12 - Table of Contents     The following securities were not included in the diluted net income (loss) per share calculation because their effect was anti-dilutive as of the periods presented (in thousands):       For the three months ended       March 31,       2022     2021   Options     6,863       7,503   Series A convertible preferred shares     -       55,643   Warrants     40,338       40,338   Total     47,201       103,484         NOTE 10 – STOCKHOLDERS ’ EQUITY   Series A Preferred Share Dividend & Share Waiver   On April 21, 2021 , the Company issued a waiver and exchange agreement (“ Waiver Agreement ”) to shareholders of its Series A Preferred shares (“ Stock Payees ”) requesting such Stock Payee's respective amount of the dividend payment (each individual Stock Payee's respective amount the “ Stock Payee Indebtedness ”) to be paid in the form of shares of Common Stock (the “ Stock Payment ”) and agreeing to consummate an exchange of such Stock Payee's right to the Stock Payee Indebtedness in cash for shares of Common Stock (the “ Exchange ”), pursuant to which the entire Stock Payee Indebtedness shall be exchanged for that number of shares of Common Stock equal to the total Stock Payee Indebtedness divided by $ 0.44313 .   On May 25, 2021 , the Company entered into a Dividend Waiver and Exchange Agreement (the “ Exchange Agreement ”), between the Company and the holders (the “ Series A Holders ”) of its Series A Preferred, pursuant to which the Company paid to the Series A Holders total consideration of approximately $ 1,650,000 (the “ Dividend Amount ”), which Dividend Amount was paid in the form of 1,736,501 shares of the Company’s Common Stock valued at $ 0.44313 per share, and approximately $ 880,000 in cash.   As of March 31, 2022, all dividend liability has been satisfied which is reflected on the Company’s condensed consolidated balance sheet.   Conversion of Series A Preferred Shares   During the three months ended March 31, 2022, the Company issued approximately 169,000 shares of Common Stock upon conversion of 750 shares of Series A Preferred.   March 2021 Private Placement   On March 19, 2021 , the Company entered into Securities Purchase Agreements by and between the Company and certain family trusts in which Mr. Brandon Stump and Mr. Ryan Stump, the Company's former Chief Executive Officer and Chief Operating Officer, respectfully, are trustees and beneficiaries (the " Purchase Agreements "), for the private placement of an aggregate of 3,517,000 shares of its Common Stock, at a purchase price per share of $ 0.853 (the " Private Placement "), which Private Placement was consummated on March 22, 2021 . The Private Placement resulted in gross proceeds to the Company of approximately $ 3.0 million. The Private Placement was undertaken pursuant to Rule 506 promulgated under the Securities Act of 1933 , as amended, and was consummated in a transaction approved by the Company's independent directors in accordance with Rule 16b - 3 (d)( 1 ) of the Securities Exchange Act of 1934 , as amended (the “ Exchange Act ”).     NOTE 11 – STOCK-BASED COMPENSATION   On May 8, 2019, our Board of Directors approved the Charlie’s Holdings, Inc. 2019 Omnibus Incentive Plan (the “ 2019 Plan ”), and the 2019 Plan was subsequently approved by holders of a majority of our outstanding voting securities on the same date. Up to 11,072,542 stock options may be granted under the 2019 Plan. The shares of Common Stock issuable under the 2019 Plan will consist of authorized and unissued shares, treasury shares, and shares purchased on the open market or otherwise.    - 13 - Table of Contents     On December 22, 2021, our Board of Directors unanimously adopted resolutions by written consent approving an amendment to increase the number of shares of Common Stock available for issuance under the 2019 Plan by 15.0 million shares, from 11,072,542 to 26,072,542 shares (the “2019 Plan Amendment ”). Furthermore, the Company received written consents approving the 2019 Plan Amendment from holders of approximately 50.3 % of our outstanding voting securities. In accordance with Rule 14c of the Exchange Act, our Board of Directors’ authority to implement the 2019 Plan Amendment became effective February 28, 2022, twenty calendar days after notification of our shareholders. The 2019 Plan Amendment will allow the Company to maintain a sufficient number of available shares for future grants under the 2019 Plan.   Non-Qualified Stock Options   The following table summarizes stock option activities during the three months ended March 31, 2022 ( all option amounts are in thousands):       Stock Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (in years)     Aggregate Intrinsic Value   Outstanding at January 1, 2022     7,123     $ 0.54       7.5     $ -   Options forfeited/expired     ( 260 )     0.44       -       -   Outstanding at March 31, 2022     6,863     $ 0.55       7.2     $ -   Options vested and exercisable at March 31, 2022     5,283     $ 0.58       7.0     $ -     As of March 31, 2022, there was approximately $ 24,000 of total unrecognized compensation expense related to non-vested stock option compensation arrangements granted under the 2019 Plan. That cost is expected to be recognized over a weighted average period of 2.4 years. For the three months ended March 31, 2022, and 2021, the Company recorded compensation expense of approximately $ 2,000 and $ 77,000 related to the granting of stock options, respectively.   Restricted Stock Awards     The following table summarizes restricted stock awards activities during the three months ended March 31, 2022 ( all share amounts are in thousands):       Number of Shares     Weighted Average Grant Date Fair Value per Share   Nonvested at January 1, 2022     1,750     $ 0.044   Restricted stock granted     5,781       0.038   Vested     -       -   Nonvested at March 31, 2022     7,531     $ 0.038     On March 2, 2022, the Company granted approximately 5.8 million restricted stock awards (“ RSAs ”) to employees, officers and directors of the Company pursuant to the 2019 Plan, as amended. The RSAs are subject to a vesting schedule and have all the rights of a shareholder of the Company with respect to voting, share adjustments, receipt of dividends (if any) and distributions (if any) on such shares.   As of March 31, 2022, there was approximately $ 253,000 of total unrecognized compensation expense related to non-vested restricted share-based compensation arrangements granted under the 2019 Plan. That cost is expected to be recognized over a weighted average period of 3.0 years. The Company recorded total stock-based compensation of approximately $ 16,000 during the three months ended March 31, 2022, related to the RSAs.     - 14 - Table of Contents Table of Contents       NOTE 12 – COMMITMENTS AND CONTINGENCIES   Leases   The Company leases office space under agreements classified as operating leases that expire on various dates through 2024. All of the Company’s lease liabilities result from the lease of its headquarters in Costa Mesa, California, which expires in 2024, its warehouse in Santa Ana, California, which expired in 2021, its office and warehouse in Denver, Colorado, which expires in 2022, and its warehouse space in Huntington Beach, California, which expires in 2022. Such leases do not require any contingent rental payments, impose any financial restrictions, or contain any residual value guarantees. Certain of the Company’s leases include renewal options and escalation clauses; renewal options have not been included in the calculation of the lease liabilities and right of use assets as the Company is not reasonably certain to exercise the options. Variable expenses generally represent the Company’s share of the landlord’s operating expenses. The Company does not act as a lessor or have any leases classified as financing leases.   The Company excludes short-term leases having initial terms of 12 months or less from ASC Topic 842, “ Leases ”, as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. The Company entered into a commercial lease for the Company’s corporate headquarters (the “ Lease ”) in Costa Mesa, California with Brandon Stump, the Company’s former Chief Executive Officer, Ryan Stump, the Company’s Chief Operating Officer, and Keith Stump, a former member of the Company’s Board of Directors. The Stumps purchased the property that is the subject of the Lease in July 2019. The Lease, which was effective as of September 1, 2019, on a month-to-month basis, was then formalized on November 1, 2019 to have a term of five years and a base rent rate of $ 22,940 per month, which rate is subject to annual adjustments based on the consumer price index, as may be mutually agreed upon by the parties to the Lease. The terms of the Lease were negotiated and approved by the independent members of the Board of Directors, and executed by Mr. David Allen, the Company’s former Chief Financial Officer, after reviewing a detailed analysis of comparable properties and rent rates compiled by an independent, third -party consultant. The total amount paid to related parties for the three months ended March 31, 2022 and 2021 was $ 68,820 and $ 69,510 , respectively.   At March 31, 2022, the Company had operating lease liabilities of approximately $ 641,000 and right of use assets of approximately $ 638,000 , which were included in the condensed consolidated balance sheet.   The following table summarizes quantitative information about the Company’s operating leases for the three months ended March 31, 2022 and 2021 (amounts in thousands):       For the three months ended       March 31,       2022     2021   Operating leases                 Operating lease cost   $ 566     $ 149   Variable lease cost     -       -   Operating lease expense     566       149   Short-term lease rent expense     -       -   Total rent expense   $ 566     $ 149         For the three months ended       March 31,       2022     2021   Operating cash flows from operating leases   $ 143     $ 113   Weighted-average remaining lease term – operating leases (in years)     2.38       2.15   Weighted-average discount rate – operating leases     12.0 %     12.0 %   - 15 - Table of Contents     Maturities of our operating leases as of March 31, 2022, excluding short-term leases, are as follows (amounts in thousands):   Nine Months Ending December 31, 2022     256   Year Ending December 31, 2023     275   Year Ending December 31, 2024     206   Total     737   Less present value discount     ( 96 ) Operating lease liabilities as of March 31, 2022   $ 641     Legal Proceedings   As of the date hereof, we are not a party to any material legal or administrative proceedings. There are no proceedings in which any of our directors, executive officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest. From time to time, the Company may be involved in various claims and counterclaims and legal actions arising in the ordinary course of business. Litigation or any other legal or administrative proceeding, regardless of the outcome, is likely to result in substantial cost and diversion of our resources, including our management’s time and attention.     NOTE 13 - INCOME TAXES   Income tax expense is comprised of domestic (US federal and state) income taxes at the applicable tax rates, adjusted for non-deductible expenses, stock compensation expenses, and other permanent differences. Our income tax provision may be significantly affected by changes to our estimates.  However, due to the full valuation allowance on our deferred tax assets, the net impact to our overall income tax expense is limited.   Under Sections 382 and 383 of the Internal Revenue Code (the “ Code ”), if a corporation undergoes an “ownership change” (generally defined as a greater than 50 percentage points (by value) in the ownership of its equity over a three -year period), the corporation’s ability to use its pre-change tax attributes to offset its post change income may be limited. We may have experienced such ownership changes in the past, and we may experience ownership changes in the future or subsequent shifts in our stock ownership, many of which are outside our control. As of December 31, 2021, we had state net operating losses (“ NOLs ”) of approximately $ 6.1 million and federal NOLs of $ 4.2 million. The federal NOLs do not expire but the state NOLs expire if not utilized before 2041. If we undergo future ownership changes, many of which may be outside of our control, our ability to utilize our NOLs and tax credit carryforwards could be further limited by Sections 382 and 383 of the Code. There is also a risk that due to regulatory changes, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise become unavailable to offset future income tax liabilities. Additionally, our NOLs and tax credit carryforwards could be limited under state law. For these reasons, even if we attain profitability, we may be unable to use a material portion of our NOLs and other tax attributes.   For the three months ended March 31, 2022, the Company’s estimate for income taxes was not determined to be significant and therefore, is not reflected in the Company’s condensed consolidated financial statements and related disclosures.     NOTE 14 - SUBSEQUENT EVENTS   The Company evaluated subsequent events for their potential impact on the consolidated condensed financial statements and disclosures through the date the consolidated condensed financial statements were available to be issued and determined that, except as set forth below, no subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.   Williamsville, New York Lease   On April 29, 2022, Charlie’s Holdings, Inc. entered into a commercial lease agreement for the Company’s sales and marketing operations in Williamsville, New York (“ Williamsville Lease ”) with Henry Sicignano Jr., a relative of the Company’s President, Henry Sicignano III. The Williamsville Lease, which became effective on May 1, 2022, has a term of one year and a base rent of $ 1,650 per month. The Williamsville Lease is considered a modified gross lease and therefore the Company will also be responsible for additional monthly expenses including gas, electricity, and internet. The Williamsville Lease was evaluated and approved by the Company’s Board of Directors and was executed by Ryan Stump, the Company’s Chief Operating Officer and a member of the Company’s Board of Directors.     - 16 - Table of Contents